BMJ Open
August 2022
Objective: The study aims to determine discontinuation among long-acting reversible contraceptive users at 3, 6, 9 and 12 months after initiation and its associated factors among new long-acting reversible contraceptive (LARC) users.
Design: A facility-based multicentre prospective cohort study was conducted with a sample size of 1766 women.
Setting: The study was conducted in five large cities of Ethiopia (Addis Ababa, Gondar, Mekelle, Jimma and Harar) between March 2017 and December 2018.